Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine in COVID-19 (COV-PREVENT)
NCT04854759Phase 3Unknown
- Sponsor
- Lublin Medical University Hospital
- Start
- Mar 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amantadine in coronavirus disease 2019 (COVID-19), sponsored by Lublin Medical University Hospital. Status: unknown.
02
Drugs
amantadine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04854759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04854759.